These case reports were submitted as supporting material for the inventor's U.S. patent application (subsequently granted at patent number 7,280,874). They give some examples of results seen with use of the DNA-related frequency determination method.
A healthy and physically active 40-year old man diagnosed by physicians with a case of Barmah Forest disease (a mosquito-transmitted viral disease endemic to certain regions of southern Asia), used a frequency-emitting device with numerous frequencies in an attempt to alleviate the clinical effects of the disease. The effects included severely debilitating arthritis-type conditions, and significant alteration of iron metabolism and levels in the blood. Lab results of blood iron levels and related factors are used by physicians to diagnose this viral disease. The patient was unable to work at his previous full-time job because of the disease. The iron level at the time of diagnosis was 10 μmol/L (at the bottom of the reference range), and remained near that level after his initial use of the device and commonly-used frequencies. The debilitating arthritis symptoms likewise continued without positive resolution, indicating the frequencies being used were not efficacious. The patient had been suffering in this manner for 10 months. The first frequency protocol was then altered to consist of a DNA frequency for the full genome, along with additional frequencies relating specifically to certain components of the virus. After the frequency protocol was changed, the patient experienced nearly full clinical recovery within two weeks, complete recovery shortly thereafter, and was able to resume his normal full-time heavy physical activity. The recovery was later confirmed by an iron test at 21.7 μmol/L, which is in normal range. No other medical protocols were changed during the time that the DNA-related frequency program was used. The man remains fully recovered with complete and permanent absence of any disease symptoms. This case has been monitored for 5 years.
A middle-aged American man in his 30s had been diagnosed with AIDS, confirmed by HIV-1 viral load and CD4 cell counts. The use of various medical and integrative alternative protocols for a period of 6-7 years had been partially but not totally successful, and included use of frequency emission devices with various frequency programs. After a period of time the viral count gradually climbed to 220,000 copies/ml. The patient at this point in time began using a new set of frequencies, each of which consisted of a frequency that corresponded to a specific gene component of the virus. There were no other changes initiated in his medical protocol at this time. Subsequent to the start and daily use of the new frequencies, a blood test three weeks later showed a virus count of 100 copies/ml. Another blood test three weeks afterwards reported a count of less than 50 copies/ml (the limit of sensitivity for that test). The latest blood test shows a count of less than 50 copies/ml. This individual was not taking any anti-viral drugs during the period of time covering this report, and had not been taking any such drugs for a period for 3.5 years prior to use of DNA-related frequencies.
In a case similar to example 3, an American woman was diagnosed with AIDS confirmed by viral load and CD cell count lab tests. The patient has experienced a drop in viral load from 15,000 copies/ml to 80 copies/ml in a period of three months, using the same frequency program as the person described in the prior example.
This example addresses a community outbreak of what physicians described as contagious shingles also resembling chickenpox (itching, painful, oozing and sometimes bloody lesions), spreading among both adults and children via physical contact. Some individuals had been suffering severe symptoms for a period of 2-3 months. Patients had been prescribed anti-viral and anti-inflammatory drugs, but the drugs did little if anything to resolve the affliction. Some patients in near desperation sought alternative assistance and commenced use of a frequency emission device. That device was programmed with a number of frequencies available from internet sources. Those frequencies had partial effects on part of the symptoms in a few but not all individuals; however, the effects were not permanent and did not resolve the affliction. The frequency program was later altered to consist of a frequencies correlating to the genome of human herpesvirus 3, which is the causative agent of chickenpox and shingles. The change in effect on the patients was immediately noticeable. For some individuals, especially the children, the itching and pain was largely resolved within 2-3 hours. For most others, the lesions were noticeably healing within 24-72 hours. A total of 30 individuals from the community were treated, and the outbreak was stopped. Many of the patients needed only one frequency session for the problem, and 7 of the more severely afflicted persons needed 2 or 3 sessions.
An elderly woman was hospitalized and diagnosed with a lung infection caused by the bacterium Gordona sputi, which became totally unresponsive to antibiotics or any other medical protocols. Her physicians told her they could do nothing more, advised her to get her affairs in order, and sent her home from the hospital. The woman began use of a frequency device using commonly available frequencies characterized by many reports as having anti-bacterial effects. The infection was not resolved and the illness continued. The program was then altered to consist of several frequencies specifically correlated with important components of the bacteria. The infection was cleared within a short time span (1-2 weeks), the woman completely recovered, and has never experienced a relapse. This case has been followed for 3-1/2 years.
A 50 year old woman employed as a nurse in a hospital acquired a herpesvirus infection via contact with a patient. The infection manifested as the condition known as Herpes Whitlow, caused by human herpesvirus 1, and manifested on her hands. As is characteristic of infections from this virus, the clinical lesions would appear and then slowly heal over a period of approximately 10 days. The woman had been suffering from this condition for 7 years, and occasionally made it difficult for her to work in her profession. At the time of the most recent outbreak of lesions, she began using a frequency corresponding to the genome of human herpesvirus 1. The lesions on her hands healed within three days, as compared to the customary 14 days healing time without use of this frequency determination method. The woman additionally stated that use of non-DNA-related frequencies sometimes made the healing process take longer, than if she had done nothing at all.
Two American missionaries working in Africa had been fighting malaria infections on a continual basis, as is common in that region. Over a four-month period, they used a frequency emission device with numerous frequency sets. By the fourth month they were able to narrow down a successful outcome to a basic set of six numbers solely consisting of frequencies that correlated with important components of the causative organism Plasmodium falciparum. One specific result was seen in a man with the following history: day 1, a mid-morning initial Quantitative Buffy Coat test showed 89 malaria parasites per 200 white blood cells (WBCs), which is equivalent to 3,560 parasites per microliter of blood. Two sessions with the aforementioned DNA-related frequencies were received by the individual later that morning and in the late afternoon. On day 2 at 8 am, the same blood test showed 10 malaria parasites per 200 WBCs (or 400 per microliter), which constitutes an 80% parasite count reduction within less than 24 hours. These results were re-checked at 9 am, with the count being 7 malaria parasites per 200 WBCs (or 280 per microliter). A different lab test performed at the same time (blood smear), gave a result of 5 malaria parasites per 200 Wing this period of frequency sessions.
Similar reductions of malaria parasite levels along with cessation of clinical symptoms were seen in several other people after using the DNA-related frequencies.
Brief comments about the case reports
It can be noted that:
1. Case numbers 1, 2, 4, 5, 6, and 7 demonstrated that desirable positive effects in laboratory and/or clinical outcome were achieved with DNA-related frequencies as calculated from the method presented in this application, as opposed to lack of such results with previously used frequencies, thus showing specificity of action with the frequencies calculated by the DNA frequency method.
2. Case #3 (HIV-1) repeats the outcome shown in case #2 (also HIV-1), showing repeatability; and case #4 clearly demonstrates repeatability over a significant group of subjects with the same illness (n=30).
3. These case reports reveal desirable outcomes against bacteria, viruses, and parasitic organisms, which indicates possible useful applicability of this method to infectious conditions caused by those classes of pathogens.
Copyright © 2005, 2007 Charlene Boehm